A cohort of startups such as Arvinas and Magnet Biomedicine are also dedicated to this field of research. Rocheowned Genentech is the latest to invest in the space. In a deal announced Wednesday  Genentech will pay drugmaker Orionis Biosciences 47 million upfront in a research collaboration conditions